Ms. Uzdienski's primary responsibilities are to generate content for the HealthpointCapital blog and report pipeline, edit and market research products, manage content for HealthpointCapital's industry database and oversee the company's presence at conferences and industry events. She joins HealthpointCapital from the publishing industry.
Recent Articles by Lauren Uzdienski
The latest news from AAOS! VITA and MAKO report 4Q09 . . . ETEX receives 510(k) . . . DePuy, Integra, Medtronic, Smith & Nephew and more announce product launches . . . SEC Drops Wright Medical Investigation . . . BioMimetic Therapeutics shares study results . . . Long-term use of bisphosphonates may increase fracture risk . . . NeoStem wins research grant more
With healthcare reform projected to cost $950 billion, the pharma, device and hospital industries have generally consented to help fund the changes - in the device industry's case, to the tune of $20 billion over the next decade, which will be realized through an excise tax proposed to be implemented in 2011. AdvaMed is pushing on behalf of the industry to lock in that $20 billion as a cap, reports Reuters. more
Wear debris and surgical technique are at the center of a New York Times article on metal-on-metal total hip components, with the paper suggesting that metal-on-metal correlates to poorer outcomes and higher revision rates. The article cites a metal-on-metal revision rate of 1-3%, with women affected more frequently than men. more
Corin, Osteotech and Integra report 4Q . . . Baxter to acquire ApaTech for up to $330.0 million . . . Intrinsic Therapeutics closes on $18.0 million of a $20.0 million round . . . FDA schedules Orthopaedic and Rehabilitation Devices Panel meeting for Menaflex . . . Aetna and United Healthcare reverse prior policies and announce that they will cover NuVasive's XLIF . . . Congress delays Medicare pay cut more
The NIH and FDA plan to collaborate on ways to bring innovative products to market sooner.
Among other actions, the two agencies plan to create a Joint Leadership Council, which will focus on encouraging researchers to think about regulatory issues early in the technology development cycle. The council will also work to incorporate the latest scientific data into the FDA review process. more